This session aims to provide insights into the advantages, including governmental strategies, polices, and other strengths, of establishing a biomedical company in Europe, encouraging Taiwanese research teams/ startups to extend their business to Europe.

Date:April 28, 2022
Time:Day 1 15:40 –16:55
Venue:C201 Video conference rm. in NBRP Bld. C
 Day 1 – 4/28 (四)
15:40 –16:55

歐洲生醫新創論壇

  • Speech 1:Introduction of the Belgium life science
    – Mehdy Oozeer | Senior Industry Specialist in Life Sciences, Wallonia Export-Investment Agency (AWEX), Belgium
    – Marc Dechamps | International Affairs Representative, Biowin – The Health Cluster of Wallonia, Belgium
  • Speech 2: Why choosing the Netherlands as a hub to start your biomedical business in Europe?
    Friso Smit | Business Development Manager, Strategic Theme Life Sciences UU-UMCU, Stichting Utrecht Science Park
  • Speech 3: Landing in France : opportunities for research and business to develop your activity in France
    Jonathan Drubay | Advisor for Innovation and Advanced Technology, Ministry of Science and Technology – Taiwan